Royal Bank of Canada’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-772
| Closed | -$25K | – | 8261 |
|
|
2022
Q2 | $25K | Sell |
772
-1,790
| -70% | -$56.6K | ﹤0.01% | 6020 |
|
|
2022
Q1 | $67K | Sell |
2,562
-2,846
| -53% | -$69.5K | ﹤0.01% | 5909 |
|
|
2021
Q4 | $129K | Buy |
5,408
+1,112
| +26% | +$27.4K | ﹤0.01% | 5746 |
|
|
2021
Q3 | $108K | Buy |
4,296
+1,445
| +51% | +$36.8K | ﹤0.01% | 5651 |
|
|
2021
Q2 | $74K | Buy |
2,851
+2,451
| +613% | +$66.7K | ﹤0.01% | 5784 |
|
|
2021
Q1 | $10K | Sell |
400
-12,832
| -97% | -$329K | ﹤0.01% | 6828 |
|
|
2020
Q4 | $265K | Sell |
13,232
-134
| -1% | -$2.62K | ﹤0.01% | 4649 |
|
|
2020
Q3 | $229K | Buy |
13,366
+67
| +0.5% | +$1.27K | ﹤0.01% | 4453 |
|
|
2020
Q2 | $290K | Sell |
13,299
-319
| -2% | -$7.3K | ﹤0.01% | 4180 |
|
|
2020
Q1 | $315K | Buy |
13,618
+10,320
| +313% | +$300K | ﹤0.01% | 3995 |
|
|
2019
Q4 | $110K | Buy |
3,298
+1,865
| +130% | +$59.8K | ﹤0.01% | 5038 |
|
|
2019
Q3 | $45K | Hold |
1,433
| – | – | ﹤0.01% | 5171 |
|
|
2019
Q2 | $37K | Hold |
1,433
| – | – | ﹤0.01% | 5436 |
|
|
2019
Q1 | $37K | Sell |
1,433
-376
| -21% | -$11.2K | ﹤0.01% | 5337 |
|
|
2018
Q4 | $62K | Sell |
1,809
-636
| -26% | -$20.7K | ﹤0.01% | 4986 |
|
|
2018
Q3 | $88K | Sell |
2,445
-955
| -28% | -$33.7K | ﹤0.01% | 4932 |
|
|
2018
Q2 | $117K | Sell |
3,400
-337
| -9% | -$11.8K | ﹤0.01% | 4733 |
|
|
2018
Q1 | $127K | Sell |
3,737
-3,588
| -49% | -$114K | ﹤0.01% | 4560 |
|
|
2017
Q4 | $280K | Buy |
7,325
+2,845
| +64% | +$114K | ﹤0.01% | 4216 |
|
|
2017
Q3 | $168K | Buy |
4,480
+3,846
| +607% | +$136K | ﹤0.01% | 4639 |
|
|
2017
Q2 | $23K | Sell |
634
-1,675
| -73% | -$60.5K | ﹤0.01% | 5488 |
|
|
2017
Q1 | $93K | Sell |
2,309
-443
| -16% | -$16.6K | ﹤0.01% | 4806 |
|
|
2016
Q4 | $95K | Buy |
2,752
+871
| +46% | +$34.2K | ﹤0.01% | 4898 |
|
|
2016
Q3 | $75K | Sell |
1,881
-4,685
| -71% | -$187K | ﹤0.01% | 4953 |
|
|
2016
Q2 | $249K | Buy |
6,566
+5,427
| +476% | +$182K | ﹤0.01% | 4247 |
|
|
2016
Q1 | $43K | Sell |
1,139
-25,534
| -96% | -$951K | ﹤0.01% | 5191 |
|
|
2015
Q4 | $1.28M | Buy |
26,673
+24,192
| +975% | +$1.12M | ﹤0.01% | 2914 |
|
|
2015
Q3 | $98K | Buy |
2,481
+243
| +11% | +$10.3K | ﹤0.01% | 4789 |
|
|
2015
Q2 | $95K | Buy |
2,238
+1,175
| +111% | +$46.8K | ﹤0.01% | 4861 |
|
|
2015
Q1 | $42K | Sell |
1,063
-692
| -39% | -$25.5K | ﹤0.01% | 5053 |
|
|
2014
Q4 | $63K | Sell |
1,755
-14,821
| -89% | -$498K | ﹤0.01% | 4947 |
|
|
2014
Q3 | $489K | Buy |
16,576
+11,772
| +245% | +$325K | ﹤0.01% | 3493 |
|
|
2014
Q2 | $121K | Buy |
4,804
+391
| +9% | +$9.67K | ﹤0.01% | 4451 |
|
|
2014
Q1 | $114K | Buy |
4,413
+967
| +28% | +$24.4K | ﹤0.01% | 4485 |
|
|
2013
Q4 | $78K | Sell |
3,446
-22,010
| -86% | -$425K | ﹤0.01% | 4709 |
|
|
2013
Q3 | $361K | Sell |
25,456
-15,499
| -38% | -$207K | ﹤0.01% | 3646 |
|
|
2013
Q2 | $560K | Buy |
+40,955
| New | +$558K | ﹤0.01% | 3054 |
|
Other funds holding NTUS
Royal Bank of Canada's NTUS Position: Q3 2022 in Review
Royal Bank of Canada sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 772 shares — an estimated $25K sold.
Royal Bank of Canada first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $1.28M in Q4 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Royal Bank of Canada reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Royal Bank of Canada sold 772 Natus Medical Inc shares in Q3 2022, an estimated $25K.
- Royal Bank of Canada first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Royal Bank of Canada's Natus Medical Inc position peaked at $1.28M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.